ES2032303T3 - Soluciones nasales. - Google Patents

Soluciones nasales.

Info

Publication number
ES2032303T3
ES2032303T3 ES198787810769T ES87810769T ES2032303T3 ES 2032303 T3 ES2032303 T3 ES 2032303T3 ES 198787810769 T ES198787810769 T ES 198787810769T ES 87810769 T ES87810769 T ES 87810769T ES 2032303 T3 ES2032303 T3 ES 2032303T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
human calcitonin
nasal solutions
meterable
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787810769T
Other languages
English (en)
Spanish (es)
Inventor
Leo Dr. Geller
Peter Glanzmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of ES2032303T3 publication Critical patent/ES2032303T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES198787810769T 1986-12-23 1987-12-18 Soluciones nasales. Expired - Lifetime ES2032303T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH520086 1986-12-23

Publications (1)

Publication Number Publication Date
ES2032303T3 true ES2032303T3 (es) 1993-02-01

Family

ID=4289609

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787810769T Expired - Lifetime ES2032303T3 (es) 1986-12-23 1987-12-18 Soluciones nasales.

Country Status (15)

Country Link
EP (1) EP0277462B1 (enExample)
JP (1) JPS63166832A (enExample)
AT (1) ATE75404T1 (enExample)
AU (1) AU608268B2 (enExample)
CA (1) CA1322330C (enExample)
DE (1) DE3778682D1 (enExample)
DK (1) DK166714B1 (enExample)
ES (1) ES2032303T3 (enExample)
GR (1) GR3004585T3 (enExample)
IL (1) IL84861A (enExample)
MY (1) MY102411A (enExample)
NZ (1) NZ223005A (enExample)
PH (1) PH24802A (enExample)
PT (1) PT86436B (enExample)
ZA (1) ZA879593B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
AU638128B2 (en) * 1990-04-10 1993-06-17 University Of Melbourne, The Calcitonin gene related peptide for the treatment of undescended testicles
JPH05506223A (ja) * 1990-04-10 1993-09-16 ザ ユニバーシティー オブ メルボルン 下降睾丸の処理のためのカルシトニン遺伝子関連ペプチド
JP3179538B2 (ja) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
GB9108634D0 (en) * 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
EP0803255A4 (en) * 1994-06-03 1999-06-30 Tsumura & Co MEDICINAL COMPOSITION
DE69901936T2 (de) * 1998-01-30 2002-11-28 Novartis Consumer Health S.A., Nyon Nasale lösungen
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
JP2002154989A (ja) * 2000-11-14 2002-05-28 Lion Corp 眼科用組成物、及び生体粘膜への薬物の滞留性向上組成物
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
IL70489A0 (en) * 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
CH657858A5 (de) * 1983-06-27 1986-09-30 Ciba Geigy Ag Substanz aus der gruppe der calcitonine.
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物

Also Published As

Publication number Publication date
NZ223005A (en) 1990-07-26
GR3004585T3 (enExample) 1993-04-28
ZA879593B (en) 1988-06-22
PT86436B (pt) 1990-11-20
JPS63166832A (ja) 1988-07-11
CA1322330C (en) 1993-09-21
PT86436A (en) 1988-01-01
EP0277462B1 (de) 1992-04-29
ATE75404T1 (de) 1992-05-15
DK676987D0 (da) 1987-12-22
AU8295587A (en) 1988-06-23
MY102411A (en) 1992-06-17
DE3778682D1 (de) 1992-06-04
IL84861A (en) 1992-09-06
AU608268B2 (en) 1991-03-28
DK166714B1 (da) 1993-07-05
DK676987A (da) 1988-06-24
PH24802A (en) 1990-10-30
EP0277462A1 (de) 1988-08-10

Similar Documents

Publication Publication Date Title
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DE3875025D1 (de) Calcitonin enthaltende zusammensetzung fuer die nasale verabreichung.
BR9303469A (pt) Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas
ATE46080T1 (de) Pharmazeutische komposition.
SE8601709L (sv) Farmaceutiskt medel samt komposition innehallande detta
SE8305485L (sv) Galeniska kompositioner innefattande kalcitonin och deras anvendning
ES2032303T3 (es) Soluciones nasales.
ATE103819T1 (de) Pharmazeutische praeparate.
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
ATE56138T1 (de) Perfluorkohlenwasserstoffe als vehikel zur verabreichung von arzneimitteln.
ATE60713T1 (de) Pharmazeutische zusammensetzung aus guar-gummi und anderen antiacida zum schutz der oeso-gastro- duodenalen schleimhaut.
ZA876411B (en) A substance or composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-dideoxy-2',3'-didehydrocytidine)for use in treating patients infected with retroviruses
ATE22282T1 (de) Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
FR2694005B1 (fr) Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
FR2672888B1 (fr) Nouvelles urees et thiourees, leur preparation et leur application en therapeutique.
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
IL76458A0 (en) Polyether ionophore,its preparation and pharmaceutical and veterinary preparations containing it
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
SE8704049D0 (sv) Novel pharmacological compounds
ES2029161A6 (es) Procedimiento para la preparacion de composiciones de carbocisteinato de zinc.
ATE1011T1 (de) 5-fluoruracil-derivate, deren herstellung und ihre pharmazeutischen zusammensetzungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 277462

Country of ref document: ES